Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 881

1.

Drugs for inflammatory bowel disease.

[No authors listed]

Med Lett Drugs Ther. 2018 Jul 2;60(1550):107-114. No abstract available.

PMID:
30036352
2.

Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease.

Ma C, Ascoytia C, McCarrier KP, Martin M, Feagan BG, Jairath V.

Dig Dis Sci. 2018 Oct;63(10):2555-2563. doi: 10.1007/s10620-018-5181-6. Epub 2018 Jun 29.

PMID:
29959726
3.

A case of Behçet's disease with various gastrointestinal findings.

Tominaga K, Kamimura K, Takahashi K, Yokoyama J, Terai S.

Clin J Gastroenterol. 2018 Oct;11(5):354-358. doi: 10.1007/s12328-018-0860-6. Epub 2018 Apr 17.

PMID:
29667077
4.

Concurrent Sweet's syndrome and myopericarditis following mesalamine therapy.

Shabtaie SA, Tan NY, Parikh RS, Papadakis KA.

BMJ Case Rep. 2018 Mar 23;2018. pii: bcr-2017-223851. doi: 10.1136/bcr-2017-223851.

PMID:
29574433
5.

[How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?]

Kim YS.

Korean J Gastroenterol. 2018 Feb 25;71(2):74-80. doi: 10.4166/kjg.2018.71.2.74. Review. Korean.

6.

The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets.

Ribaldone DG, Vernero M, Saracco GM, Pellicano R, Finocchiaro F, Caviglia GP, Astegiano M.

Scand J Gastroenterol. 2018 Feb;53(2):141-146. doi: 10.1080/00365521.2017.1405070. Epub 2017 Dec 11.

7.

Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide.

Yeo J, Woo HS, Lee SM, Kim YJ, Kwon KA, Park DK, Kim JH, Kim KO, Chung JW.

Intest Res. 2017 Oct;15(4):529-534. doi: 10.5217/ir.2017.15.4.529. Epub 2017 Oct 23.

8.

Amblyopia due to intermediate uveitis as the presenting symptom of Crohn's disease in a 6-year-old boy.

Symeonidis C, Matsou A, Tzetzi D, Dermenoudi M, Brazitikos P, Mataftsi A.

J AAPOS. 2017 Dec;21(6):512-514. doi: 10.1016/j.jaapos.2017.07.218. Epub 2017 Nov 2.

PMID:
29102673
9.

Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.

Guizzetti L, Zou G, Khanna R, Dulai PS, Sandborn WJ, Jairath V, Feagan BG.

J Crohns Colitis. 2018 Jan 24;12(2):167-177. doi: 10.1093/ecco-jcc/jjx130.

PMID:
29028958
10.

European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease.

Doherty G, Katsanos KH, Burisch J, Allez M, Papamichael K, Stallmach A, Mao R, Berset IP, Gisbert JP, Sebastian S, Kierkus J, Lopetuso L, Szymanska E, Louis E.

J Crohns Colitis. 2018 Jan 5;12(1):17-31. doi: 10.1093/ecco-jcc/jjx101. Review.

PMID:
28981623
11.

Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.

Allocca M, Landi R, Bonovas S, Fiorino G, Papa A, Spinelli A, Furfaro F, Peyrin-Biroulet L, Armuzzi A, Danese S.

Digestion. 2017;96(3):166-172. doi: 10.1159/000480231. Epub 2017 Sep 14.

PMID:
28903094
12.

Inhibitory Potency of Marketed Drugs for Ulcerative Colitis and Crohn's Disease on PEPT1.

Miyake M, Fujishima M, Nakai D.

Biol Pharm Bull. 2017;40(9):1572-1575. doi: 10.1248/bpb.b17-00181.

13.

Management of Crohn's Disease After Surgical Resection.

Singh S, Nguyen GC.

Gastroenterol Clin North Am. 2017 Sep;46(3):563-575. doi: 10.1016/j.gtc.2017.05.011. Review.

PMID:
28838415
14.

Oral and upper gastrointestinal Crohn's disease.

Laube R, Liu K, Schifter M, Yang JL, Suen MK, Leong RW.

J Gastroenterol Hepatol. 2018 Feb;33(2):355-364. doi: 10.1111/jgh.13866. Review.

PMID:
28708248
15.

Alicaforsen for the treatment of inflammatory bowel disease.

Jairath V, Khanna R, Feagan BG.

Expert Opin Investig Drugs. 2017 Aug;26(8):991-997. doi: 10.1080/13543784.2017.1349753. Epub 2017 Jul 6. Review.

PMID:
28670932
16.

Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury.

Durando M, Tiu H, Kim JS.

Am J Kidney Dis. 2017 Dec;70(6):869-873. doi: 10.1053/j.ajkd.2017.05.013. Epub 2017 Jun 29.

17.

Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.

Derwa Y, Gracie DJ, Hamlin PJ, Ford AC.

Aliment Pharmacol Ther. 2017 Aug;46(4):389-400. doi: 10.1111/apt.14203. Epub 2017 Jun 27. Review.

PMID:
28653751
18.

Chronic paracoccidioidmycosis in a woman with Crohn Disease.

Tavares Dos Santos H, Augusto Benevenuto de Andrade B, Fernandes D, Caxias Travassos D, Bufalino A.

Dermatol Online J. 2017 Apr 15;23(4). pii: 13030/qt1gp8z9gx.

PMID:
28541872
19.

Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.

Mak LY, Ng SC, Wong IOL, Li MKK, Lo FH, Wong MTL, Leung CM, Tsang SWC, Chan KH, Sze SF, Shan EHS, Lam BCY, Hui AJ, Hung IFN, Leung WK.

J Gastroenterol Hepatol. 2018 Jan;33(1):141-149. doi: 10.1111/jgh.13817.

PMID:
28475813
20.

Is Mesalamine Effective for the Induction of Remission in Crohn's Disease?

Bonovas S, Peyrin-Biroulet L, Danese S.

Inflamm Bowel Dis. 2017 May;23(5):E22-E23. doi: 10.1097/MIB.0000000000001124. No abstract available.

PMID:
28426460

Supplemental Content

Loading ...
Support Center